{"pageContent": "The standard treatments of localized prostate cancer include surgical resection and/or radiotherapy. Recently in 2016, Zhao et al. described a tool to predict which patients will most likely gain from postoperative radiotherapy. Such a method can personalize treatment plan by maximizing benefit but minimizing harm.", "metaData": {"source": "Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/25961317/"}}